The synergistic antitumor effect of combined Anti-Human Epidermal Growth Factor Receptor 2 (HER2) antibody and Gamma Interferon therapy to Ab resistant breast cancer cells
This study shows that combining anti-HER2 antibody with gamma interferon improves antitumor effects against HER2-positive breast cancer resistant to anti-HER2 therapy.
The Showa University Journal of Medical Sciences · Jan 1, 2019Peer-reviewedCancer Biology